BridgeBio Pharma grants 57,853 restricted stock units to 32 new employees

BBIO•2026-10-16

BridgeBio Pharma approved restricted stock units covering 57,853 common shares for 32 new employees on October 14, 2026.

1. Equity awards

The awards will vest 25% on November 16, 2027, followed by quarterly vesting of one-twelfth of the remaining shares. Vesting is subject to continued employment with BridgeBio Pharma or one of its subsidiaries on each vesting date.

BridgeBio Pharma grants 57,853 restricted stock units to 32 new employees

1. Equity awards

Related News

London leads UK private-sector growth in September, NatWest report shows

Odyssey Marine seeks shareholder approval for share issuance tied to American Ocean Minerals merger

Russia takes over more EU companies' assets over Ukraine support

NiSource announces long-term agreement with Microsoft expected to increase customer savings and support Indiana’s economic growth

Brazil economic activity up 0.3% in August, central bank says